Title:
QUINAZOLINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/216190
Kind Code:
A1
Abstract:
The present invention relates to a compound, which has cancer treatment activity. The present invention also relates to a preparation method for the compound and a pharmaceutical composition containing the compound. (I)
More Like This:
Inventors:
WU HAO (CN)
LU YUAN (CN)
YU JUN (CN)
ZHOU XIAO (CN)
LI BOYAN (CN)
HE JIANGQI (CN)
FU SHUIBIAO (CN)
YANG RONGWEN (CN)
LI YABIN (CN)
WANG CHAO (CN)
WANG JIABING (CN)
LAN HONG (CN)
DING LIEMING (CN)
LU YUAN (CN)
YU JUN (CN)
ZHOU XIAO (CN)
LI BOYAN (CN)
HE JIANGQI (CN)
FU SHUIBIAO (CN)
YANG RONGWEN (CN)
LI YABIN (CN)
WANG CHAO (CN)
WANG JIABING (CN)
LAN HONG (CN)
DING LIEMING (CN)
Application Number:
PCT/CN2020/085704
Publication Date:
October 29, 2020
Filing Date:
April 20, 2020
Export Citation:
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D471/10; A61K31/517; A61P35/00
Domestic Patent References:
WO2018143315A1 | 2018-08-09 | |||
WO2018143315A1 | 2018-08-09 |
Foreign References:
CN108779097A | 2018-11-09 | |||
CN107849022A | 2018-03-27 | |||
CN106488910A | 2017-03-08 |
Other References:
"Design of Prodrugs", 1985, ELSEVIER, article "Design of Prodrugs"
See also references of EP 3967695A4
See also references of EP 3967695A4
Download PDF: